Jessica Kenison-White
Scientific Director Immunocodex
Seminars
Thursday 4th June 2026
Encoding Active Antigen-Specific Immune Tolerance Using mRNA-LNPs for the Treatment of Autoimmune Diseases
1:30 pm
- Highlighting the advantages of incorporating an active immune modulator into antigen-specific tolerance strategies
- Exploring critical factors in applying mRNA-LNP technology to autoimmune conditions, including challenges and successes targeting immune cell delivery
- Presenting preclinical findings from autoimmune disease models
